FimmCyte

Basel, Switzerland

FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.

$1.1M raised

Feb 2024

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has FimmCyte raised?

FimmCyte has raised $1.1M in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.

Who are FimmCyte's investors?

FimmCyte's investors include BioInnovation Institute, Venture Kick, Innosuisse, BaseLaunch, InnoBooster.

Where is FimmCyte headquartered?

FimmCyte is headquartered in Basel, Switzerland.

What does FimmCyte do?

FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.

What stage is FimmCyte at?

FimmCyte is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 28, 2024.

MLA

"FimmCyte — Funding & Investors." VCBacked, February 28, 2024, https://www.vcbacked.co/company/fimmcyte. Accessed July 2, 2026.

APA

VCBacked. (2024). FimmCyte — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/fimmcyte

Wikipedia (cite web)

{{cite web |title=FimmCyte — Funding & Investors |url=https://www.vcbacked.co/company/fimmcyte |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 28, 2024.